Severe Imatinib-Associated Skin Rash in Gastrointestinal Stromal Tumor Patients: Management and Clinical Implications
Sook Ryun Park, Min-Hee Ryu, Baek-Yeol Ryoo, Mo Youl Beck, In Soon Lee, Mi Jung Choi, Mi Woo Lee, Yoon-Koo Kang
Cancer Res Treat. 2016;48(1):162-170. Published online 2015 Sep 1 DOI: https://doi.org/10.4143/crt.2015.017
Citations to this article as recorded by 
Lichenoid and psoriasiform drug induced rush during imatinib therapy: a clinical case
Albina N. Khlebnikova, Valentina E. Shikina, Gayane E. Bagramova
Almanac of Clinical Medicine.2024; 51(7): 417. CrossRef
Assessment of Skin Toxicity in an in Vitro Reconstituted Human Epidermis Model Using Deep Learning
Fangyao Hu, Sara F. Santagostino, Dimitry M. Danilenko, Min Tseng, Jochen Brumm, Philip Zehnder, Kai Connie Wu
The American Journal of Pathology.2022; 192(4): 687. CrossRef
Health-Related Quality of Life and Side Effects in Gastrointestinal Stromal Tumor (GIST) Patients Treated with Tyrosine Kinase Inhibitors: A Systematic Review of the Literature
Deborah van de Wal, Mai Elie, Axel Le Cesne, Elena Fumagalli, Dide den Hollander, Robin L. Jones, Gloria Marquina, Neeltje Steeghs, Winette T. A. van der Graaf, Olga Husson
Cancers.2022; 14(7): 1832. CrossRef
Clinical outcomes and prognostic factors for patients with high‐risk gastrointestinal stromal tumors treated with 3‐year adjuvant imatinib
Yeong Hak Bang, Min‐Hee Ryu, Hyung‐Don Kim, Hyung Eun Lee, Yoon‐Koo Kang
International Journal of Cancer.2022; 151(10): 1770. CrossRef
Cutaneous toxicity of FDA-approved small-molecule kinase inhibitors
Jiangxia Du, Hao Yan, Zhifei Xu, Bo Yang, Qiaojun He, Xiaohong Wang, Peihua Luo
Expert Opinion on Drug Metabolism & Toxicology.2021; 17(11): 1311. CrossRef
Dermatologic adverse events of Bcr-Abl tyrosine kinase inhibitors
E. A. Shatokhina, A. G. Turkina, L. S. Kruglova
Russian journal of hematology and transfusiology.2020; 65(2): 154. CrossRef
Experience in Using Jumihaidokuto and Orengedokuto for Skin Disorders Caused by Molecular Target Drugs
Koki MORI, Tatsuya HIROSE, Koji TANAKA, Atsuko TAKEDA, Masahiro UNO, Hajime TAKAGI
Kampo Medicine.2020; 71(1): 30. CrossRef
Systemic Steroid Treatment for Imatinib-Associated Severe Skin Rash in Patients with Gastrointestinal Stromal Tumor: A Phase II Study
Eo Jin Kim, Min-Hee Ryu, Sook Ryun Park, Mo Youl Beck, Woo Jin Lee, Mi Woo Lee, Yoon-Koo Kang
The Oncologist.2020; 25(11): e1785. CrossRef
Review of adverse cutaneous reactions of pharmacologic interventions for COVID-19: A guide for the dermatologist
Antonio Martinez-Lopez, Carlos Cuenca-Barrales, Trinidad Montero-Vilchez, Alejandro Molina-Leyva, Salvador Arias-Santiago
Journal of the American Academy of Dermatology.2020; 83(6): 1738. CrossRef
Cystic acne due to imatinib therapy for chronic myelocytic leukemia
Andrew Hwang, Andrew Iskandar, Michael del Rosario, Constantin A Dasanu
Journal of Oncology Pharmacy Practice.2019; 25(4): 972. CrossRef
Long‐term survival outcome with tyrosine kinase inhibitors and surgical intervention in patients with metastatic or recurrent gastrointestinal stromal tumors: A 14‐year, single‐center experience
Jwa Hoon Kim, Min‐Hee Ryu, Changhoon Yoo, Heejung Chae, Hana Na, Moyoul Beck, Beom Su Kim, Moon‐Won Yoo, Jeong Hwan Yook, Byung Sik Kim, Ki‐Hun Kim, Chan Wook Kim, Yoon‐Koo Kang
Cancer Medicine.2019; 8(3): 1034. CrossRef
A successful approach to overcome imatinib-induced skin toxicity in a GIST patient
Ingrid M.E. Desar, Carla M.L. van Herpen, Nielka P. van Erp, Suzanne E.J. Kaal, Peter C.M. van de Kerkhof, Winette T.A. van der Graaf
Anti-Cancer Drugs.2016; 27(6): 576. CrossRef